Subscribe
Logo small
Search

Izabela Leszczyna: We want to meet patients' expectations

MedExpress Team

Piotr Wójcik

Published Dec. 13, 2024 12:45

Izabela Leszczyna: We want to meet patients' expectations - Header image
fot. MZ
31 new therapies are included in the draft list of reimbursed drugs that will take effect in the new year. As we reported in recent weeks, rivaroxaban will be reimbursed in new indications. This is good news for patients with atrial fibrillation. The price of the cheapest substitute will be around PLN 10.

- In 2025, we will want to meet patients' expectations, just as we did in 2024. There are more and more of these new therapies, and we are doing our best to make sure that what shows up on the market enters the list of reimbursed drugs as soon as possible," assured Health Minister Izabela Leszczyna, outlining the most important changes that the January list will bring.

- We have 31 substances. The most anticipated is rivaroxaban. Until now, a pack of this drug cost several hundred zlotys. The cheapest equivalent will be available for as little as PLN 10. This substance is used, among other things, in the prevention of strokes. The fact that we have this drug and it will be cheaper is our greatest...

Content locked

To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].

If you already have an account, please log in

Szukaj nowych pracowników

Dodaj ogłoszenie o pracę za darmo

Lub znajdź wyjątkowe miejsce pracy!

Read also